MetaCap

Glaukos (GKOS) vs Medline (MDLN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Medline is the larger company by market cap ($48.75 billion vs $14.05 billion), about 3.5 times the size. On valuation, Medline trades at a lower forward P/E (24.0x vs 169.5x for Glaukos). Medline converts more of its revenue into profit, with a net margin of 4.1% versus -37.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

GKOS+111.09%MDLN-9.66%
+127%+49%-30%
Dec 17, 20251 yearNov 20, 2026
GKOS+104.19%MDLN-11.07%
+118%+44%-31%
Dec 15, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

GKOS versus MDLN key metrics
MetricGKOSMDLN
Share price$237.31$37.04
Market cap$14.05B$48.75B
1-day change-0.33%-2.11%
YTD return+110.18%-11.81%
1-year return+138.22%—
5-year return+421.56%—
P/E ratio (TTM)—84.18
Forward P/E169.5023.98
EPS (TTM)$-2.95$0.44
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$507.44M$28.43B
Revenue growth (YoY)+32.33%—
Net income (latest FY)$-187.69M$1.16B
Gross margin55.72%26.44%
Operating margin-39.33%7.78%
Net margin-36.99%4.08%
52-week high$255.19$50.88
52-week low$93.96$31.37
Distance from 52-week high-7.00%-27.20%
Analyst consensusstrong_buybuy
Avg. price target upside+2.76%+23.52%
Average volume1.19M9.55M
Shares outstanding59.20M878.66M
Employees1,09445,000
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Medline is about 3.5 times larger than Glaukos by market value ($48.75B vs $14.05B).
  • Medline is more profitable, keeping 4.1 cents of every revenue dollar as net income versus -37.0 cents for Glaukos.

About Glaukos

GKOS stock →

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor.

Health Care · Medical/Dental Instruments · 1,094 employees

About Medline

MDLN stock →

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally.

Health Care · Medical/Dental Instruments · 45,000 employees

GKOS vs MDLN FAQ

Which is bigger, Glaukos or Medline?

Medline (MDLN) is larger, with a market capitalization of $48.75B compared with $14.05B for Glaukos (GKOS).

Are Glaukos and Medline in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons